@article {Giorgini694, author = {Margherita Giorgini and Claudia Marchetti and Violante Di Donato and Jacopo Tesei and Natalina Manci and Pierluigi Benedetti Panici}, title = {Limits of 18F-Fluorodeoxyglucose Positron Emission Tomography in Recurrence Diagnosis of Borderline Ovarian Tumor}, volume = {20}, number = {5}, pages = {694--697}, year = {2010}, doi = {10.1111/IGC.0b013e3181da2912}, publisher = {BMJ Specialist Journals}, abstract = {Most borderline ovarian tumors (BOT) occur in young women and exhibit a low malignant behavior. Nevertheless, an accurate long-term follow-up is required because, frequently, recurrence arises after many years from primary treatment, especially in patients affected by BOT with invasive peritoneal implants, which have a worse prognosis. We report the case of a pelvic recurrence of serous BOT firstly suspected by physical examination but misdiagnosed by 18F-fluorodeoxyglucose positron emission tomography and computed tomography and identified only by magnetic resonance imaging, 7 years after primary treatment. We also reviewed the literature concerning the role of 18F-fluorodeoxyglucose positron emission tomography in the management and follow-up of BOT.}, issn = {1048-891X}, URL = {https://ijgc.bmj.com/content/20/5/694}, eprint = {https://ijgc.bmj.com/content/20/5/694.full.pdf}, journal = {International Journal of Gynecologic Cancer} }